Psychedelic Sector News – Weekly Extractions: August 13, 2022

In this week’s episode of Weekly Extractions, Adam talks about some of the highlights coming out of the psychedelic sector this week.

Psychedelic Invest’s own, Adam Tubero, shares his thoughts on the Compass Pathways lawsuit, MindMed’s former Chief Medical Officer now an activist shareholder, Cybin’s at-the-money market offering, and the implications of Mydecin’s four directors resigning.

Extraction #1: Compass Pathways is Being Sued

Extraction #2: Cybin Modifies Their At-the-Money Offering

Extraction #3: MindMed Shelves a Program

Extraction #4: MindMed’s Former CMO Wants to Change the Company

Extraction #5: Four Directors Resign from Mydecine

Please like, share, comment, and subscribe on YouTube. There will be plenty more Weekly Extractions in the weeks to come.